This Government Contract opportunity from Department Of Veterans Affairs was posted on October 10, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
6505--Lurasidone HCL Tablets Major Pharmaceuticals - 12/10/2024 - 12/9/2025
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Veterans Affairs, specifically Nac Pharmaceuticals, has awarded contract 36E79725D0001 to The Harvard Drug Group, L.L.C. for the procurement of Lurasidone HCL Tablets. This award, associated with solicitation 36E79724R0022 and NAICS code 325412, is valued at 10,056,938.10 dollars. The contract was officially awarded on October 10, 2024, and covers a performance period starting December 10, 2024, and ending December 9, 2025. The contracting office is located in Hines, Illinois, with Ray Roldan serving as the designated Contract Specialist for this action.
General Info
Contract Value
$0Place of Performance
IL, USASet-Aside
Award Issued Date
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
